Healthcare provider profile · identity verified

Syed Mohsin Raza, MD

Internal Medicine · HACKETTSTOWN, NJ · NPI 1194704585

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	627	166
Amlodipine Besylate	Amlodipine Besylate	545	133
Levothyroxine Sodium	Levothyroxine Sodium	527	106
Rosuvastatin Calcium	Rosuvastatin Calcium	428	105
Metformin Hcl	Metformin Hcl	309	95
Metoprolol Succinate	Metoprolol Succinate	300	82
Gabapentin	Gabapentin	233	65
Losartan Potassium	Losartan Potassium	231	58
Eliquis	Apixaban	195	30
Azelastine Hcl	Azelastine Hcl	187	93
Metoprolol Tartrate	Metoprolol Tartrate	184	51
Montelukast Sodium	Montelukast Sodium	173	52
Escitalopram Oxalate	Escitalopram Oxalate	163	32
Famotidine	Famotidine	149	41
Clopidogrel	Clopidogrel Bisulfate	143	33
Pantoprazole Sodium	Pantoprazole Sodium	143	41
Trulicity	Dulaglutide	138	22
Pravastatin Sodium	Pravastatin Sodium	130	31
Duloxetine Hcl	Duloxetine Hcl	128	29
Lisinopril	Lisinopril	125	34
Potassium Chloride	Potassium Chloride	118	29
Furosemide	Furosemide	116	33
Hydralazine Hcl	Hydralazine Hcl	116	29
Prednisone	Prednisone	116	72
Torsemide	Torsemide	109	30
Valsartan	Valsartan	106	25
Methylprednisolone	Methylprednisolone	101	75
Cefuroxime	Cefuroxime Axetil	99	71
Ezetimibe	Ezetimibe	98	36
Allopurinol	Allopurinol	96	26
Tizanidine Hcl	Tizanidine Hcl	88	29
Fluticasone Propionate	Fluticasone Propionate	85	27
Tamsulosin Hcl	Tamsulosin Hcl	81	28
Azithromycin	Azithromycin	79	61
Venlafaxine Hcl Er	Venlafaxine Hcl	73	11
Fenofibrate	Fenofibrate	72	17
Trazodone Hcl	Trazodone Hcl	65	17
Omeprazole	Omeprazole	63	17
Pregabalin	Pregabalin	62	suppressed
Mirtazapine	Mirtazapine	60	20
Zolpidem Tartrate	Zolpidem Tartrate	60	12
Farxiga	Dapagliflozin Propanediol	58	13
Albuterol Sulfate Hfa	Albuterol Sulfate	54	26
Methenamine Hippurate	Methenamine Hippurate	53	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	53	23
Donepezil Hcl	Donepezil Hcl	52	suppressed
Enalapril Maleate	Enalapril Maleate	51	15
Baclofen	Baclofen	48	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	17
Diclofenac Sodium	Diclofenac Sodium	47	19
Finasteride	Finasteride	46	suppressed
Synthroid	Levothyroxine Sodium	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	12
Betamethasone Dipropionate	Betamethasone Dipropionate	42	27
Myrbetriq	Mirabegron	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	41	suppressed
Meloxicam	Meloxicam	41	23
Sertraline Hcl	Sertraline Hcl	41	suppressed
Simvastatin	Simvastatin	41	13
Mounjaro	Tirzepatide	40	suppressed
Glimepiride	Glimepiride	39	13
Nystatin	Nystatin	39	12
Bupropion Xl	Bupropion Hcl	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	33
Cefdinir	Cefdinir	36	30
Temazepam	Temazepam	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	28
Lorazepam	Lorazepam	33	11
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Celecoxib	Celecoxib	32	17
Olmesartan Medoxomil	Olmesartan Medoxomil	32	12
Ozempic	Semaglutide	32	suppressed
Atenolol	Atenolol	31	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Ramipril	Ramipril	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	25	suppressed
Calcitriol	Calcitriol	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Cephalexin	Cephalexin	25	19
Hydrochlorothiazide	Hydrochlorothiazide	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Carvedilol	Carvedilol	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Lacosamide	Lacosamide	23	suppressed
Metronidazole	Metronidazole	23	19
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	13
Folic Acid	Folic Acid	22	suppressed
Repaglinide	Repaglinide	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Restasis	Cyclosporine	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Lagevrio (Eua)	Molnupiravir	15	15
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Bicalutamide	Bicalutamide	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Colchicine	Colchicine	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Darifenacin Er	Darifenacin Hydrobromide	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Mesalamine Dr	Mesalamine	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Linzess	Linaclotide	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error